Long-term Mortality of Patients With Tuberculous Meningitis in New York City: A Cohort Study
Author(s) -
Christopher Vinnard,
Liza King,
Sonal S. Munsiff,
Aldo Crossa,
Kentaro Iwata,
Jotam G. Pasipanodya,
Douglas Proops,
Shama D. Ahuja
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw763
Subject(s) - medicine , tuberculosis , hazard ratio , death certificate , isoniazid , retrospective cohort study , mortality rate , cohort , tuberculous meningitis , mycobacterium tuberculosis , cause of death , cohort study , pediatrics , surgery , confidence interval , disease , pathology
Tuberculous meningitis (TBM) is the most devastating clinical presentation of infection with Mycobacterium tuberculosis; delayed initiation of effective antituberculosis therapy is associated with poor treatment outcomes. Our objective was to determine the relationship between drug resistance and 10-year mortality among patients with TBM.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom